Trends in Methadone Distribution for Pain Treatment, Methadone Diversion, and Overdose Deaths - United States, 2002-2014

被引:51
|
作者
Jones, Christopher M. [1 ]
Baldwin, Grant T. [2 ]
Manocchio, Teresa [1 ]
White, Jessica O. [1 ]
Mack, Karin A. [3 ]
机构
[1] US Dept HHS, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA
[2] CDC, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA
[3] CDC, Div Anal Res & Practice Integrat, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA
来源
关键词
RISK;
D O I
10.15585/mmwr.mm6526a2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
What is already known about this topic? Use of the prescription opioid methadone for treatment of pain, rather than for treatment of opioid use disorder, has been identified as an important contributor to the rise in opioid-related overdose deaths. In recent years, a number of actions to reduce the use of methadone for pain treatment have been taken. What is added by this report? During 2002-2006, the national distribution rate of methadone increased, on average, 25.1% per year, methadone-involved drug overdose deaths increased 22.1% per year, and methadone diversion increased 24.3% per year. After 2006, methadone distribution declined 3.2% per year, and methadone-involved overdose deaths declined 6.5% per year. Rates of methadone diversion continued to increase during 2006-2009, but substantially more slowly, and then declined an average of 12.8% per year beginning in 2010. By sex, most age groups, race/ethnicity, and U.S. Census region, the methadone overdose death rate peaked during 2005-2007 and declined in subsequent years. Persons aged 25-54 years had the highest overdose death rates during the study period. There was no significant change in the overdose death rate trend among persons aged ≥65 years, who also had the lowest overdose death rate. Among persons aged 55-64 years, the rate of methadone overdose deaths continued to increase through 2014. What are the implications for public health practice? Additional clinical and public health policy changes are needed to further reduce methadone-related harm, especially among persons aged ≥55 years. © 2016, Department of Health and Human Services. All rights reserved.
引用
收藏
页码:667 / 671
页数:5
相关论文
共 50 条
  • [41] Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs
    Jones, Christopher M.
    Compton, Wilson M.
    Han, Beth
    Baldwin, Grant
    Volkow, Nora D.
    JAMA PSYCHIATRY, 2022, 79 (09) : 932 - +
  • [42] Abstention from Drug Use and Delinquency Increasing among Youth in the United States, 2002-2014
    Vaughn, Michael G.
    Nelson, Erik J.
    Oh, Sehun
    Salas-Wright, Christopher P.
    DeLisi, Matt
    Holzer, Katie J.
    SUBSTANCE USE & MISUSE, 2018, 53 (09) : 1468 - 1481
  • [43] Trends in drug overdose deaths in England and Wales 1993-98: methadone does not kill more people than heroin
    Hickman, M
    Madden, P
    Henry, J
    Baker, A
    Wallace, C
    Wakefield, J
    Stimson, G
    Elliott, P
    ADDICTION, 2003, 98 (04) : 419 - 425
  • [44] Trends in Intentional and Unintentional Opioid Overdose Deaths in the United States, 2000-2017
    Olfson, Mark
    Rossen, Lauren M.
    Wall, Melanie M.
    Houry, Debra
    Blanco, Carlos
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (23): : 2340 - 2342
  • [45] Trends in drug offers among adolescents in the United States, 2002–2014
    Oh S.
    Salas-Wright C.P.
    Vaughn M.G.
    Health & Justice, 5 (1)
  • [46] Involvement of methadone in opioid-related deaths and prescribing and dispensing conditions: current situation in Europe and the United States
    Chaaban, Sarah
    Girod, Laurence
    Fernandez, Augusto
    Abou Taam, Malak
    THERAPIE, 2022, 77 (06): : 782 - 783
  • [47] Typology of laws restricting access to methadone treatment in the United States: A latent class analysis
    Conway, Anna
    Krawczyk, Noa
    McGaffey, Frances
    Doyle, Sheri
    Baaklini, Vanessa
    Marshall, Alison D.
    Treloar, Carla
    Davis, Corey S.
    Colledge-Frisby, Samantha
    Grebely, Jason
    Cerda, Magdalena
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2023, 119
  • [48] LIVER TRANSPLANTATION FOR CHRONIC HCV INFECTION IN THE UNITED STATES 2002-2014: AN ANALYSIS OF THE UNOS/OPTN DATABASE
    Dultz, G.
    Graubard, B.
    Martin, P.
    Welker, M. W.
    Borg, B.
    Zeuzem, S.
    McGlynn, K. A.
    Welzel, T. M.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S537 - S537
  • [49] Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters
    Bandara, Sachini
    Kennedy-Hendricks, Alene
    Merritt, Sydney
    Barry, Colleen L.
    Saloner, Brendan
    ADDICTION, 2021, 116 (12) : 3473 - 3481
  • [50] Trends in Drug Overdose Deaths by Intent and Drug Categories, United States, 1999-2022
    Nguyen, Anallely
    Wang, Jing
    Holland, Kristin M.
    Ehlman, Daniel C.
    Welder, Laura E.
    Miller, Kimberly D.
    Stone, Deborah M.
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2024, 114 (10) : 1081 - 1085